There are at least four different existing or proposed interpretive criteria for the disk diffusion susceptibility testing of ticarcillin and ticarcillin plus clavulanic acid (T/C). To assess these criteria, 570 gram-negative bacillary isolates were tested for susceptibility to ticarcillin and T/C by both disk diffusion and broth microdilution methods. These included 53 strains of the family Enterobacteriaceae selected for ticarcillin resistance and high-level P-lactamase production. The broth microdilution test results were more influenced by increased 0-lactamase production than were disk diffusion results. The combination of clavulanic acid (CA), a potent ,-lactamase inhibitor, with ticarcillin has proven to be an effective therapeutic agent (4, 11). However, there is some recent controversy regarding the in vitro susceptibility testing interpretive criteria for ticarcillin plus CA (T/C), as well as ticarcillin alone. In 1984, we recommended the 75/10-,ug T/C disk for disk diffusion susceptibility testing and tentatively suggested the same interpretive zone diameter breakpoints that were recommended for ticarcillin alone (2). The National Committee for Clinical Laboratory Standards (NCCLS) adopted these recommendations for disk susceptibility testing of T/C (5). At least two problems exist with these NCCLS criteria. (i) The MIC breakpoints for dilution susceptibility testing of T/C, ticarcillin, and related penicillins found in one NCCLS document (6) differ from the MIC correlates of the disk diffusion breakpoints found in another NCCLS document (5). (ii) There appears to be a high frequency of discrepancies between disk diffusion and broth dilution susceptibility test results with T/C when members of the family Enterobacteriaceae that produce high levels of plasmid-mediated ,B-lactamases are tested (10).
increased 0-lactamase production than were disk diffusion results. In the absence of published data indicating which of the two standardized test methods better predicts clinical response, we conclude that until such data are available the more conservative National Committee for Clinical Laboratory Standards tentative criteria for tests with members of the Enterobacteriaceae are appropriate. Our data do not support the use of separate T/C interpretive criteria for Pseudomonas spp. and members of the Enterobacteriaceae. The appropriateness of different interpretive criteria needs further evaluation.
The combination of clavulanic acid (CA), a potent ,-lactamase inhibitor, with ticarcillin has proven to be an effective therapeutic agent (4, 11) . However, there is some recent controversy regarding the in vitro susceptibility testing interpretive criteria for ticarcillin plus CA (T/C), as well as ticarcillin alone. In 1984, we recommended the 75/10-,ug T/C disk for disk diffusion susceptibility testing and tentatively suggested the same interpretive zone diameter breakpoints that were recommended for ticarcillin alone (2) . The National Committee for Clinical Laboratory Standards (NCCLS) adopted these recommendations for disk susceptibility testing of T/C (5). At least two problems exist with these NCCLS criteria. (i) The MIC breakpoints for dilution susceptibility testing of T/C, ticarcillin, and related penicillins found in one NCCLS document (6) differ from the MIC correlates of the disk diffusion breakpoints found in another NCCLS document (5) . ( ii) There appears to be a high frequency of discrepancies between disk diffusion and broth dilution susceptibility test results with T/C when members of the family Enterobacteriaceae that produce high levels of plasmid-mediated ,B-lactamases are tested (10) .
The NCCLS recently published new tentative interpretive criteria for this group of drugs which are designed to minimize the discrepancies between the disk diffusion and dilution susceptibility test documents (7, 8) . These tentative criteria provide different breakpoints for Pseudomonas spp. and non-Pseudomonas gram-negative bacteria (NPGNB). Sanders et al. proposed yet another set of criteria for T/C disk diffusion tests designed to reduce discrepant categorization of members of the Enterobacteriaceae producing high levels of P-lactamase (10) . The purpose of the present study was to evaluate the cited interpretive criteria by simultaneously testing a large number of clinical isolates by disk diffusion and broth microdilution methods. To with routine clinical isolates, but a significant (fourfold) reduction in T/C MICs was seen with 4 ,ug of CA per ml in the test system when producers of high levels of P-lactamase were tested. Scattergrams for ticarcillin MICs plotted against inhibitory zone diameters are displayed in Fig. 1 for these organisms, illustrating the two NCCLS breakpoints. Table 3 provides the calculated error rates for each subset of organisms when each of the sets of interpretive criteria was applied: criteria A, original NCCLS-recommended criteria (5); criteria B, tentative NCCLS criteria for Pseudomonas spp. (7); criteria C, tentative NCCLS criteria for NPGNB (7) ; and criteria D, proposed criteria of Sanders et al. for members of the Enterobacteriaceae (10) .
Application of criteria A to ticarcillin yielded high very major error rates (false-susceptibility disk diffusion results) for NPGNB (2.6%) and Pseudomonas spp. (3.1%). These were reduced to acceptable levels with the application of the tentative NCCLS criteria, i.e., to 0.5% for NPGNB and to 1.0% for Pseudomonas spp. Application of criteria B yielded the lowest error rates for both NPGNB and Pseudomonas spp.
The corresponding scattergrams for T/C are given in Fig.  2 . NPGNB ( Fig. 2A and B) had an unacceptably high very major error rate with criteria A (1.4%), but these errors were eliminated by the other criteria. However, the total error rate was highest with criteria D (10.0%), owing exclusively to minor discrepancies.
No very major errors occurred with T/C testing of Pseudomonas spp. by any of the criteria evaluated. Criteria A and C yielded the lowest total error rates with this genus (13.5%), but criteria A and B gave a 2.1% major error rate compared with no major errors with criteria C (Table 3) . Table 4 summarizes the T/C error rates obtained when the same interpretive criteria were applied to the 382 isolates of Enterobacteriaceae among the 517 bacteria tested, as well as the 53 members of the Enterobacteriaceae producing high levels of ,-lactamase. Scattergrams for these organisms with T/C are shown in Fig. 3 . No major errors occurred with any of the criteria. The very major error rates were <l% for ail criteria with the 382 unselected clinical strains. For the 53 producers of high levels of ,-lactamase, the very major error rates were extremely high for criteria A, B, and C (77, 59, and 9%, respectively), but no very major errors occurred with criteria D. The minor and total error rates were more than twice as high for criteria D (10.5%) than for any of the 
DISCUSSION
None of the cited tentative or proposed interpretive criteria for the disk diffusion susceptibility testing of T/C is strongly supported by the data in this study. On the other hand, these data do raise a number of questions that should be resolved before definitive interpretive criteria for T/C and related drugs are selected.
Microbiologically, our data provide no support for the concept of different interpretive criteria for Pseudomonas spp. and NPGNB (Table 3) . We recognize that the MICs of the drugs tend to be higher for Pseudomonas spp. than for NPGNB and that in the absence of susceptibility data for the specific infecting organisms it is appropriate to treat with higher doses when Pseudomonas spp. are present or suspected. However, we are unaware of any data to support the assumption that Pseudomonas aeruginosa is more susceptible than Escherichia coli when the MIC for each is the same; a Ticar, Ticarcillin with no CA; T/C-2, ticarcillin with 2 ktg of CA per ml;
T/C-4, ticarcillin with 4 k.g of CA per ml.
e.g., with a T/C MIC of 64 ,ug/ml, P. aeruginosa would be considered susceptible but E. coli would be moderately susceptible according to the latest NCCLS proposal (7). This double standard is potentially confusing to both the microbiologist and the clinician and, in our opinion, should be avoided unless and until there are clinical outcome data to support it.
Production of high levels of P-lactamase by certain members of the Enterobacteriaceae may prove to be a significant problem for T/C susceptibility testing. Both microdilution and disk diffusion methods correctly recognized all 53 strains producing high levels of g-lactamase to be resistant to ticarcillin. On the other hand, significant interpretive discrepancies occurred with those strains between the two methods of testing when T/C was tested, which confirms the findings of Sanders et al. (10) . That the increased P-lactamase production is a major contributor to the discrepant results is supported by the fact that ticarcillin MICs for the strains producing high levels of ,B-lactamase were fourfold lower when ticarcillin was combined with 4 ,ug of CA per ml than when it was combined with the currently recommended 2 ,ug of CA per ml (Table 2) . A similar effect of higher concentrations of CA on ticarcillin MICs against ticarcillinresistant enteric bacilli was previously reported (9) . By contrast, the T/C MICs for the unselected members of the Enterobacteriaceae were reduced less than one-quarter of a twofold dilution when 4 ,ug of CA was used in lieu of 2 ,ug/ml (Tables 1 and 2 ). Assuming this to be true, it would be difficult tojustify the use of criteria D at this time for T/C disk diffusion testing of members of the Enterobacteriaceae since the error rates for the usual isolates of Enterobacteriaceae are twice as high as those obtained with the other criteria. Since the error rates for criteria B and C are comparable, the selection of either should depend upon whether .256 or .128 ,ug/ml is the more appropriate MIC resistance breakpoint clinically. In the absence of clinical data to help clearly decide between these two MIC breakpoints, it could be argued that criteria C is preferable because it is much less likely to yield very major errors with the rare producers of high levels of 13-lactamase.
Although CA is a potent P-lactamase inhibitor, it can also be a ,3-lactamase inducer (12) . There is no evidence that this property has any role in the aforementioned problem with members of the Enterobacteriaceae. However, it may play a role in the few instances of antagonism observed (Table 5) . If type I ,3-lactamases induced by CA resulted in production of high levels seen in the ticarcillin-resistant strains, this could explain the antagonism. Of the 12 instances detected by the microdilution test, only 2 were also detected by the standard disk diffusion test. However, if the disk diffusion plates were held an extra 24 h, many developed colonies within the original T/C zone of inhibition. This suggests the presence of a resistant subpopulation that is capable of growth once the antibiotic is inactivated.
In summary, we agree that the susceptibility criteria for ticarcillin, T/C, and related penicillins, as published by the NCCLS (5, 6) , need revision and better correlation between the two major testing methods. On the other hand, an essential element for establishing appropriate standards (viz., clinical data) is lacking. This is particularly true of clinical response to T/C of infections with the rare members of the Enterobacteriaceae producing high levels of ,B-lactamase. Once the clinical responses are better characterized, one can standardize the in vitro susceptibility methods and criteria to better reflect clinical response. Until then, the tentative NCCLS criteria (7, 8) appear to be appropriate.
